Preparation of vaccines against H5N1 influenza
John Wood(Women's and Children's Hospital), G. C. Schild(National Institute for Biological Standards and Control), Carolyn Nicolson(National Institute for Biological Standards and Control), Una Dunleavy(National Institute for Biological Standards and Control), Diane Major(National Institute for Biological Standards and Control), James S. Robertson(Brookhaven National Laboratory), Robert W. Newman(National Institute for Biological Standards and Control)
Cited by 17
Related Papers
Location and primary structure of a major antigenic site for poliovirus neutralization
|Nature|1983|194
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.
|Proceedings of the National Academy of Sciences|1984|189
Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
|Vaccine|2004|156
Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
|Emerging infectious diseases|2009|150
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
|Influenza and Other Respiratory Viruses|2007|148